Decoy Therapeutics Corrects Warrant Inducement Announcement
Boston, Massachusetts, U.S., September 22, 2026 Decoy Therapeutics, Inc., a clinical-stage biotechnology company developing antiviral therapeutics, has issued a...
biotechnology financing
Advertisement
CervoMed Secures $10 Million to Advance Brain Disease Pipeline
BOSTON, June 18, 2026 CervoMed Inc., a clinical-stage biotechnology company focused on developing therapies for age-related neurological disorders, has...
CNS Pharmaceuticals Launches Strategy to Build Neurology and Oncology Drug Pipeline
Houston, Texas, United States — March 11, 2026 Biotechnology company CNS Pharmaceuticals has announced the launch of a new...
Dianthus Therapeutics Prices $250M Public Offering
New York, United States — March 10, 2026 Biotechnology company Dianthus Therapeutics has announced the pricing of an upsized...
BioXcel Therapeutics Secures $8M Registered Direct Offering
NEW HAVEN, Connecticut — March 10, 2026 Biotechnology company BioXcel Therapeutics Inc. has announced a registered direct offering expected...
Advertisements
Xenon Pharmaceuticals Prices $650M Public Offering
VANCOUVER, British Columbia & BOSTON — March 10, 2026 Global biotechnology company Xenon Pharmaceuticals Inc. has announced the pricing...
Dianthus Therapeutics Launches $400M Public Offering Plan
New York, United States & Waltham, Massachusetts – March 9, 2026 Dianthus Therapeutics, Inc., a clinical-stage biotechnology company focused...
Sensorion Secures €60M to Advance Gene Therapies for Hearing Loss
MONTPELLIER, France | January 28, 2026 — Sensorion, a clinical-stage biotechnology company focused on hearing loss disorders, announced a...
Advertisement
